全文获取类型
收费全文 | 2526篇 |
免费 | 243篇 |
国内免费 | 173篇 |
出版年
2024年 | 2篇 |
2023年 | 76篇 |
2022年 | 88篇 |
2021年 | 168篇 |
2020年 | 176篇 |
2019年 | 187篇 |
2018年 | 173篇 |
2017年 | 121篇 |
2016年 | 109篇 |
2015年 | 130篇 |
2014年 | 167篇 |
2013年 | 234篇 |
2012年 | 131篇 |
2011年 | 149篇 |
2010年 | 91篇 |
2009年 | 106篇 |
2008年 | 114篇 |
2007年 | 117篇 |
2006年 | 103篇 |
2005年 | 74篇 |
2004年 | 68篇 |
2003年 | 49篇 |
2002年 | 44篇 |
2001年 | 47篇 |
2000年 | 22篇 |
1999年 | 19篇 |
1998年 | 20篇 |
1997年 | 20篇 |
1996年 | 16篇 |
1995年 | 16篇 |
1994年 | 11篇 |
1993年 | 11篇 |
1992年 | 8篇 |
1991年 | 13篇 |
1990年 | 2篇 |
1989年 | 8篇 |
1988年 | 10篇 |
1987年 | 7篇 |
1986年 | 7篇 |
1985年 | 4篇 |
1983年 | 1篇 |
1982年 | 3篇 |
1981年 | 5篇 |
1980年 | 3篇 |
1979年 | 4篇 |
1976年 | 1篇 |
1975年 | 2篇 |
1974年 | 1篇 |
1973年 | 1篇 |
1972年 | 2篇 |
排序方式: 共有2942条查询结果,搜索用时 31 毫秒
1.
TRPM蛋白家族是一类表达于多种哺乳动物细胞中广泛存在的离子通道。近年来发现它们在维持某些特定生理功能中起关
键作用且与人类疾病密切相关。研究显示氧化应激可使TRPM离子通道功能异常导致疾病发生、发展。TRPM亚家族的三个成
员,TRPM2,TRPM4 和TRPM7 均受氧化应激的调控,其功能改变、增加或缺失与炎症及免疫系统的激活、神经退行性疾病和神经
系统疾病、心血管疾病、癌症及糖尿病,代谢紊乱和骨疾病等疾病紧密联系。本文就近年来氧化应激调控的TRPM离子通道与人
类疾病的关系做简要综述。此外,文章也将探讨它们作为药物设计靶点和工具的应用前景。 相似文献
2.
《Bioorganic & medicinal chemistry》2014,22(5):1626-1633
The 2-acylamino-5-nitro-1,3-thiazole derivatives (1–14) were prepared using a one step reaction. All compounds were tested in vitro against four neglected protozoan parasites (Giardia intestinalis, Trichomonas vaginalis, Leishmania amazonensis and Trypanosoma cruzi). Acetamide (9), valeroylamide (10), benzamide (12), methylcarbamate (13) and ethyloxamate (14) derivatives were the most active compounds against G. intestinalis and T. vaginalis, showing nanomolar inhibition. Compound 13 (IC50 = 10 nM), was 536-times more active than metronidazole, and 121-fold more effective than nitazoxanide against G. intestinalis. Compound 14 was 29-times more active than metronidazole and 6.5-fold more potent than nitazoxanide against T. vaginalis. Ureic derivatives 2, 3 and 5 showed moderate activity against L. amazonensis. None of them were active against T. cruzi. Ligand efficiency indexes analysis revealed higher intrinsic quality of the most active 2-acylamino derivatives than nitazoxanide and metronidazole. In silico toxicity profile was also computed for the most active compounds. A very low in vitro mammalian cytotoxicity was obtained for 13 and 14, showing selectivity indexes (SI) of 246,300 and 141,500, respectively. Nitazoxanide showed an excellent leishmanicidal and trypanocidal effect, repurposing this drug as potential new antikinetoplastid parasite compound 相似文献
3.
Rashi Verma Monika Yadav Rajabrata Bhuyan Shweta Aggarwal Arnab Nayek 《Journal of receptor and signal transduction research》2016,36(6):601-616
Computer-aided antibody engineering has been successful in the design of new biologics for disease diagnosis and therapeutic interventions. Interleukin-6 (IL-6), a well-recognized drug target for various autoimmune and inflammatory diseases such as rheumatoid arthritis, multiple sclerosis, and psoriasis, was investigated in silico to design potential lead antibodies. Here, crystal structure of IL-6 along with monoclonal antibody olokizumab was explored to predict antigen–antibody (Ag???Ab)-interacting residues using DiscoTope, Paratome, and PyMOL. Tyr56, Tyr103 in heavy chain and Gly30, Ile31 in light chain of olokizumab were mutated with residues Ser, Thr, Tyr, Trp, and Phe. A set of 899 mutant macromolecules were designed, and binding affinity of these macromolecules to IL-6 was evaluated through Ag???Ab docking (ZDOCK, ClusPro, and Rosetta server), binding free-energy calculations using Molecular Mechanics/Poisson Boltzman Surface Area (MM/PBSA) method, and interaction energy estimation. In comparison to olokizumab, eight newly designed theoretical antibodies demonstrated better result in all assessments. Therefore, these newly designed macromolecules were proposed as potential lead antibodies to serve as a therapeutics option for IL-6-mediated diseases. 相似文献
4.
5.
The incidence and severity of chronic lung diseases is growing and affects between 100 and 150 million people worldwide and is associated with a significant rate of mortality. Unfortunately, the initial cause that triggers most chronic lung diseases remains unknown and current available therapies only ameliorate, but do not cure the disease. Thus, there is a need for identification of new targets and development of novel therapies especially for those most severely affected. IL-6, like other inflammatory cytokines, has been shown to be elevated in different lung diseases, but it was considered a byproduct of ongoing inflammation in the lung. However, recent studies support a dissociation of IL-6 from inflammation in the lung and suggest that this cytokine plays an active role in pathogenesis of asthma and, in all likelihood, COPD. IL-6 may therefore be a germane target for treatment of these and other chronic lung disease. Here, we provide an overview of the studies in mouse models and human patients that provide support for the involvement of IL-6 in lung diseases. 相似文献
6.
D. Heylen O. Schmidt H. Dautel L. Gern H. Kampen J. Newton J. Gray 《Medical and veterinary entomology》2019,33(3):360-366
Determination of the ratios of natural stable isotopes (13C/12C and 15N/14N) in unfed Ixodes ricinus nymphs and adults, which, in their previous stage, fed on captive wild rodents (Apodemus sylvaticus and Myodes glareolus), wild birds (Parus major and Cyanistes caeruleus) or domestic ruminants (Ovis aries and Bos taurus), demonstrated that it is possible to identify each host category with confidence. First, the tick–blood spacing, which is the difference between values obtained from ticks and the blood of hosts that they had fed on in the previous stage, was consistent (152 spacings investigated from 15 host individuals in total). Second, potential confounding factors (tick age and sex) did not affect the discriminatory power of the isotope patterns, nor did different rearing conditions (room temperature vs. 4 °C) or the duration of development (maximum of 430 days). The findings that the tick–blood isotope spacings, across a diverse range of hosts, were similar and predictable, and that confounders had little or no effect on this, strongly support the usage of the isotope approach. Because each of the host categories has a different role in the population dynamics of I. ricinus and in tick‐borne pathogen ecology, the method described here has great potential for the clarification of tick and tick‐borne pathogen ecology in the field. 相似文献
7.
8.
The multifactorial nature of Parkinson’s disease necessitates the development of new chemical entities with inherent ability to address key pathogenic processes. To this end, two series of new symmetrical 1,2- and 1,4-bis(2-aroyl/alkoylimino-5-(2-methoxy-2-oxoethylidene)-4-oxo-thiazolidin-3-yl)benzene derivatives (3a–g and 5a–e) were synthesized in good yields by the cyclization of 1,2- and 1,4-bis(N′-substituted thioureido)benzene intermediates with dimethyl acetylenedicarboxylate (DMAD) in methanol at ambient temperature. The bis-iminothiazolidinone compounds were investigated in vitro for their inhibition of monoamine oxidase (MAO-A & MAO-B) enzymes with the aim to identify new and distinct pharmacophores for the treatment of neurodegenerative disorders like Parkinson’s disease. Most of the designed compounds exhibited good inhibitory efficacy against monoamine oxidases. Compound 5a was identified as the most potent inhibitor of MAO-A depicting an IC50 value of 0.001 μM, a 4-fold stronger inhibitory strength compared to standard inhibitor (clorgyline: IC50 = 0.0045 μM). Molecular docking studies provided insights into enzyme-inhibitor interactions and a rationale for the observed inhibition towards monoamine oxidases. 相似文献
9.
Michael Haber M. Elizabeth Halloran Ira M. Longini Luc Watelet 《Biometrical journal. Biometrische Zeitschrift》1995,37(1):25-38
A deterministic model for the transmission of an acute infectious disease in a heterogeneous, nonrandomly mixing population is developed. This model facilitates the estimation of transmission probabilities from the observed attack rates. If some of the members of the population are vaccinated, then the vaccine efficacy (VE), defined as the relative reduction in the transmission probability due to vaccination, can be estimated. We provide several estimators of VE, depending on the amount of information available on the mixing pattern and on the action of the vaccine. We show that if vaccinated persons increase the frequency of their contacts with infectious persons, then estimators ignoring this change in behavior may substantially underestimate the VE. 相似文献
10.